KP Tissue Inc (KPT)
Toronto Exchange · Canada · prices in CAD · close of 23 Oct 2026
Key indicators
| Last close | CAD 11.66 |
|---|---|
| 52-week range | 9.26 – 13.78 |
| Return, 1 month / 3 months | −9.4% / −7.4% |
| Return, 1 year / 3 years | +32.5% / +51.6% |
| Trend | Above 200-day, below 50-day |
| RSI (14) | 43 |
| Volatility (1 year) | 17.1% |
| Worst drawdown (1 year) | -14.6% |
| Average daily value traded | 0.19M CAD |
| Dividend yield | 6.7% |
Market X-Ray price-based
Five-year price chart navy: price · brown: 200-day average
About the company
KP Tissue Inc is a Canadian company whose economic interest is in Kruger Products, a maker of household tissue paper goods. Through that business it supplies bathroom tissue, paper towels, facial tissue and napkins to consumers and to commercial and industrial customers. Its consumer brands are familiar in Canadian homes and include Cashmere, SpongeTowels, Purex and Scotties. The company is based in Canada and its products reach households and businesses through retail and commercial channels.
On this site KP Tissue Inc appears as a stock on the Toronto Exchange (Canada), code KPT, with prices in Canadian dollars (CAD). Our dividend records, which start in 2019, show payments in 8 different calendar years. The Market X-Ray on this page is price-based and compares it with other stocks on the same exchange; it does not measure how healthy the business is.
Summary
KP Tissue Inc (KPT) trades on the Toronto Exchange in Canada. It last closed at CAD 11.66 on 23 October 2026.
Its price-based Market X-Ray is 65 out of 100 (a fair price profile), ranking 215 of 870 stocks on this exchange. The score describes how the stock has traded: trend, momentum, risk, liquidity and dividends, each ranked against the other stocks on its own exchange. It does not measure how healthy or cheap the business is.
Over the last year the price rose 32.5% and over the last three months it fell 7.4%. Returns are price returns, dividends not included.
Fundamental measures (valuation, growth, financial health) are not shown: we do not yet hold financial statements for this market.
The five lenses in numbers each metric is ranked against the other stocks on Toronto Exchange
| Lens and metric | Value | Score | Reading |
|---|---|---|---|
| Trend | 64 · Fair | Mixed trend against its averages. | |
| Above 200-day average | 1.3% | ||
| From 52-week high | -14.3% | ||
| Momentum | 60 · Fair | Typical recent returns for this exchange. | |
| 3-month return | -7.4% | ||
| 6-month return | 8.1% | ||
| 12-month return, skipping the last month | 46.2% | ||
| Stability (higher is calmer) | 88 · Strong | Calmer than most: low volatility and shallow drawdowns. | |
| Volatility, 1 year (lower is calmer) | 17.1% | ||
| Worst drawdown, 1 year (smaller is calmer) | -14.6% | ||
| Liquidity | 32 · Weak | Thinly traded: prices can jump and exits can be hard. | |
| Average daily value traded | 0.19M CAD | ||
| Zero-volume days | 0.0% | ||
| Income | 76 · Strong | Dividend is high and has been paid regularly. | |
| Dividend yield | 6.7% | ||
| Years with dividends | 6 |
Strengths
- Stability (higher is calmer): Calmer than most: low volatility and shallow drawdowns.
- Income: Dividend is high and has been paid regularly.
Weak spots
- Liquidity: Thinly traded: prices can jump and exits can be hard.
Returns
| 1 week | −3.2% |
|---|---|
| 1 month | −9.4% |
| 3 months | −7.4% |
| 6 months | +8.1% |
| 1 year | +32.5% |
| 3 years | +51.6% |
| 5 years | +56.7% |
Signals
| 50-day / 200-day average | 12.30 / 11.51 |
|---|---|
| Golden / death cross (60 days) | None |
| New 52-week high | No |
| Bullish RSI divergence | No |
| Average daily range (ATR) | 0.29 |
Technical summary
Recent dividends
| Ex-dividend date | Amount per share |
|---|---|
| 29 Sep 2026 | CAD 0.2100 |
| 30 Jun 2026 | CAD 0.2100 |
| 31 Mar 2026 | CAD 0.1800 |
| 31 Dec 2025 | CAD 0.1800 |
| 29 Sep 2025 | CAD 0.1800 |
| 30 Jun 2025 | CAD 0.1800 |
How to read this report
Every number comes from end-of-day prices and dividends. The Market X-Ray describes how the stock has traded, ranked against the other stocks on Toronto Exchange; it does not measure how healthy or cheap the business is. The fundamental X-Ray (financial health, valuation, growth) needs financial statements, which we hold today for US stocks. See the methodology page. Educational only, not financial advice.